Nordion Inc (NDN.TO)

BUY
Great success story. Seems to reach a price level indicating a further move up and then languishes. Good value
BUY
Having trouble getting their proteomics division IPO'd. Well diversified company. Good long term stock.
BUY
Prefers buying Hemasol via MDS
BUY
Buy @ $20/25. Solid company and will grow.
TOP PICK
Not only value through their labs, but some exciting venture assets.
BUY
Good way to play Hemasol.
BUY
Doing well over all. Watch their quarterly reports.
WAIT
Looking at this as a possible BUY. Has some long term prospects but still have some things to work out. Wait for a couple of quarters.
TOP PICK
Holding good shares in proteomics, plus good labs
BUY
In his "Bullet Proof" portfolio.
WAIT
Be cautious until the new IPO (protoenomics?) comes out.
DON'T BUY
Good company. Spinning off their proteomics division? A long term
BUY
Likes to play health care through MDS. Good long term
BUY
Likes the varied health care niches. Well run. Conservative . Great management. A steal at $20, but OK at $25
TOP PICK
A conservative play in biotechs & health. Break up = $25 a share. Lots of free cash flow. Cash flow growth 23%
Showing 196 to 210 of 229 entries